Home
Socratec R&D GmbH

Socratec R&D GmbH Market Share Analysis for June 2026

Industry: N/A

Domainsocratec-pharma.de

Year Founded1998

Employees51 - 200

Annual Revenue$15M - $25M

Socratec R&D GmbH

Socratec R&D GmbH (including company regionals)

socratec-pharma.de

See more website traffic and engagement information

Socratec R&D GmbH Revenue up to June 2026 is 15M - 25M

revenue generated by Socratec R&D GmbH top domains

Socratec R&D GmbH top domains revenue over 3 years

Revenue for Socratec R&D GmbH top domains

socratec-pharma.de15M - 25M

See more with Sales Intelligence

Total visits to Socratec R&D GmbH's top domains

Understand Socratec R&D GmbH market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

socratec-pharma.de521

See more with Sales Intelligence

Avg. visit duration in Socratec R&D GmbH's top domains

Analyze Socratec R&D GmbH engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

socratec-pharma.de--

See more with Sales Intelligence

Avg. pageviews on Socratec R&D GmbH's top domains

See how Socratec R&D GmbH keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

socratec-pharma.de1.01

See more with Sales Intelligence

Socratec R&D GmbH top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Socratec R&D GmbH

These are the website technologies, by industry, used by Socratec R&D GmbH top domains

Mobile (2)

Meta Viewport

Content Management System (1)

WordPress

Email Services (1)

1 and 1 Email Hosting

News & Signals from Socratec R&D GmbH

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSocratec Pharma attends event German Pharm-Tox Summit.Socratec Pharma will be at the German Pharm-Tox Summit (GPTS) and its colleague Dr. Ruwen Böhm will co-chair the session on Pharmacogenetic testing as an inclusion/exclusion criterion in clinical trials and consequences for the label by AGAH.

NewsSocratec Pharma attended event ACT EU workshop on Feb 18th '25.Last week, SocraTec had the privilege to be part of the ACT EU workshop on the ICH E6(R3) guideline in Amsterdam, together with other industry experts as well as regulators, investigators, and patient representatives.